...
首页> 外文期刊>Cell death & disease. >Sumoylation-deficient Prdx6 gains protective function by amplifying enzymatic activity and stability and escapes oxidative stress-induced aberrant Sumoylation
【24h】

Sumoylation-deficient Prdx6 gains protective function by amplifying enzymatic activity and stability and escapes oxidative stress-induced aberrant Sumoylation

机译:缺乏糖化作用的Prdx6通过增强酶的活性和稳定性来获得保护功能,并逃避了氧化应激诱导的异常糖化作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Aberrant Sumoylation of protein(s) in response to oxidative stress or during aging is known to be involved in etiopathogenesis of many diseases. Upon oxidative stress, Peroxiredoxin (Prdx) 6 is aberrantly Sumoylated by Sumo1, resulting in loss of functions and cell death. We identified lysines (K) 122 and 142 as the major Sumo1 conjugation sites in Prdx6. Intriguingly, the mutant Prdx6 K122/142?R (arginine) gained protective efficacy, increasing in abundance and promoting glutathione (GSH) peroxidase and acidic calcium-independent phospholipase A 2 (aiPLA 2 ) activities. Using lens epithelial cells derived from targeted inactivation of Prdx6 ?/? gene and relative enzymatic and stability assays, we discovered dramatic increases in GSH-peroxidase (30%) and aiPLA 2 (37%) activities and stability in the K122/142?R mutant, suggesting Sumo1 destabilized Prdx6 integrity. Prdx6 ?/?LECs with EGFP-Sumo1 transduced or co-expressed with mutant TAT-HA-Prdx6K122/142?R or pGFP-Prdx6K122/142?R were highly resistant to oxidative stress, demonstrating mutant protein escaped and interrupted the Prdx6 aberrant Sumoylation-mediated cell death pathway. Mutational analysis of functional sites showed that both peroxidase and PLA 2 active sites were necessary for mutant Prdx6 function, and that Prdx6 phosphorylation (at T177 residue) was essential for optimum PLA 2 activity. Our work reveals the involvement of oxidative stress-induced aberrant Sumoylation in dysregulation of Prdx6 function. Mutant Prdx6 at its Sumo1 sites escapes and abates this adverse process by maintaining its integrity and gaining function. We propose that the K122/142R mutant of Prdx6 in the form of a TAT-fusion protein may be an easily applicable intervention for pathobiology of cells related to aberrant Sumoylation signaling in aging or oxidative stress.
机译:响应于氧化应激或衰老过程中蛋白质异常的糖基化与许多疾病的发病机理有关。在氧化应激时,过氧化物酶(Prdx)6被Sumo1异常Sumoylated,导致功能丧失和细胞死亡。我们确定赖氨酸(K)122和142是Prdx6中主要的Sumo1共轭位点。有趣的是,突变体Prdx6 K122 / 142?R(精氨酸)获得了保护功效,增加了丰度并促进了谷胱甘肽(GSH)过氧化物酶和酸性钙非依赖性磷脂酶A 2(aiPLA 2)的活性。使用源自Prdx6 ?/?基因靶向失活的晶状体上皮细胞以及相关的酶和稳定性测定,我们发现GSH过氧化物酶(30%)和aiPLA 2(37%)活性和稳定性显着增加。在K122 / 142?R突变体中,提示Sumo1破坏了Prdx6的完整性。与突变TAT-HA-Prdx6K122 / 142?R或pGFP-Prdx6K122 / 142?R转导或共同表达的带有EGFP-Sumo1的Prdx6 ?/? LEC对氧化应激高度抗性,证明了突变蛋白逃脱并中断了Prdx6异常Sumoylation介导的细胞死亡途径。功能位点的突变分析表明,过氧化物酶和PLA 2活性位点对于突变Prdx6功能都是必需的,并且Prdx6磷酸化(在T177残基处)对于最佳PLA 2活性至关重要。我们的工作揭示了氧化应激诱导的异常Sumoylation参与Prdx6功能失调。通过保持其完整性和获得功能,在其Sumo1位点处的突变体Prdx6逃脱并减轻了这一不利过程。我们建议,TAT融合蛋白形式的Prdx6的K122 / 142R突变体可能是一种易于应用的干预措施,用于与衰老或氧化应激中异常的Sumoylation信号传导有关的细胞的病理学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号